Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Nieuwe inzichten chlamydia: GGD past testbeleid aan
jul 2024 | Antibioticaresistentie, SOA, Venereologie